Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Positive hemodynamic results reported in phase III trial of tezosentan

Feb. 19, 2001

New Aventis compounds block Kv1.5 potassium channels

Feb. 19, 2001

MicroHeart obtains exclusive license to angiogenic/antiinflammatory compound

Feb. 19, 2001

Novel alpha1B-adrenoceptor antagonists from Toray particularly useful in hypertension

Feb. 15, 2001

New benzimidazoles useful for atherosclerosis Rx designed at Japanese lab

Feb. 15, 2001

ApoA-I Milano shows activity in mouse model of atherosclerotic disease

Feb. 15, 2001

Independent cardiovascular study with Dusa's Levulan begins

Feb. 14, 2001

Adenosine derivatives from CV Therapeutics useful in treatment, diagnosis of CAD

Feb. 13, 2001

Former SmithKline Beecham provides macrophage scavenger receptor antagonists

Feb. 9, 2001

Benzamide vasopressin antagonists in the Fujisawa pipeline

Feb. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...